Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

Please provide your email address to receive an email when new articles are posted on . Researchers found heightened odds for mortality among veterans with no sleep apnea vs. with mild to moderate ...

Medical News Today looks at three key studies and their key findings that highlight and further confirm the connection ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

Often brushed off as loud snoring, obstructive sleep apnea is a serious disorder that repeatedly cuts oxygen during sleep, strains the heart and brain, and raises the risk of hypertension, stroke and ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...